$ Value
$0
Shares
4,426
Price
$0
Filed
Dec 2
Insider
Name
Onyia Jude
Title
Chief Scientific Officer
CIK
0001894425
Roles
Transaction Details
Transaction Date
2025-11-29
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
18,129
Footnotes
Shares withheld by Neurocrine Biosciences, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. | Each Restricted Stock Unit represents a contingent right to receive one share of the Neurocrine Common Stock. | This RSU was granted to the Reporting Person on November 29, 2021. In accordance with the terms of the RSU, the award vested as to 4,425 shares on November 29, 2022, vested as to 4,425 shares on November 29, 2023, vested as to 4,426 shares on November 29, 2024, and vested as to 4,426 shares on November 29, 2025, subject to the terms and conditions of the award.
Filing Info
Onyia Jude's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-20 | NBIX | G | $0 |
| 2026-02-13 | NBIX | M | $0 |
| 2026-02-13 | NBIX | F | $180K |
| 2026-02-13 | NBIX | M | $0 |
| 2026-02-13 | NBIX | F | $182K |
| 2026-02-13 | NBIX | A | $0 |
| 2026-02-13 | NBIX | F | $1.3M |
| 2026-02-13 | NBIX | M | $0 |
| 2026-02-13 | NBIX | M | $0 |
| 2026-02-13 | NBIX | A | $0 |
Other Insiders at NBIX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| GORMAN KEVIN CHARLES | — | — | 2026-02-13 |
|
Lippoldt Darin
Chief Legal Officer
|
— | — | 2026-02-13 |
|
Gano Kyle
Chief Executive Officer
|
— | — | 2026-02-13 |
|
BENEVICH ERIC
Chief Commercial Officer
|
— | — | 2026-02-13 |
|
ABERNETHY MATT
Chief Financial Officer
|
— | — | 2026-03-04 |
|
Cooke Julie
Chief Human Resources Officer
|
— | — | 2026-02-13 |
|
Keswani Sanjay Chandru
Chief Medical Officer
|
— | — | 2026-02-13 |
|
Onyia Jude
Chief Scientific Officer
|
— | — | 2026-02-20 |
|
Boyer David W.
Chief Corp. Affairs Officer
|
— | — | 2026-02-13 |
|
Delaet Ingrid
Chief Regulatory Officer
|
— | — | 2026-02-13 |